Skip to main content
. 2020 Jan 21;11(3):216–236. doi: 10.18632/oncotarget.27400

Figure 3. GSEA of genes associated with sensitivity or resistance to prexasertib in pan-cancer cell line panel.

Figure 3

Bar plot of top hallmark gene sets associated with sensitivity (red) or resistance (blue) using FDR<0.05 (A) and representative enrichment plots highlighting top-scoring gene sets associated with prexasertib sensitivity (B) or intrinsic resistance (C).